The Mexican National Association of Drug Manufacturers ANAFAM was accepted in September 2023 as a member of the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines.
ANAFAM Board Member and former President Dagoberto Cortés, commented “It is an honour for ANAFAM to participate as a member of IGBA, whose goals we fully share. We are delighted to work together to ensure patient global access to affordable, quality-assured, and effective medicines and obtain a stronger voice in Mexico”.
The Mexican regulator COFEPRIS is one of the 15 Regulatory Members of ICH, added David Gaugh, IGBA Chair, welcoming ANAFAM’s membership. “One of our goals is to be a representative body for the global generic and biosimilar medicines industries by attracting the widest assembly of members who are committed to subscribing to our standards and common principles, and to matching the continuous expansion of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)”, he said.